Comparative measures of inspiratory vs expiratory volumes show a penumbra of lung tissue at higher risk of damage from existing COPD.
The first study of antibiotic use in outpatients with COPD exacerbations found that doxycycline plus prednisone did not prolong the time between exacerbations.
Azithromycin therapy is more effective at preventing COPD exacerbations among patients with Helicobacter pylori infection than among those who are H pylori seronegative.
In a real-world study, once-daily, single-inhaler triple therapy reduced COPD exacerbations more than twice-daily double therapy.
The patient presented with obesity and reduction in bilateral hip flexion strength and shoulder abduction.
Chest CT is not currently part of recommended routine COPD care.
Associated cardiovascular side effects of bronchodilators may reduce prescription rates in patients with COPD with comorbid cardiovascular disease.
Odds of ischemic heart disease-related morbidity, mortality increased after new opioid use
Patients with persistent hypercapnia following acute exacerbation of COPD, home noninvasive ventilation with home oxygen therapy prolonged readmission time.
Two phase 3 clinical development programs showed improved breathing in children and adolescents with moderate-to-severe asthma regardless of allergic status.
Multiple studies presented at ATS 2017 indicated that indacaterol/glycoptrrolate inhaler therapy results in clinically significant improvements in COPD-related quality of life.
No difference was noted in all-cause readmission rates in the intervention vs non-intervention groups.
The release of a new autonomous approach for terminating the COPD crisis has been lead by the National Heart, Lung and Blood Institute (NHLBI).
Researchers examined the relationship between COPD and right and left ventricular morphometry to determine which patients may better respond to beta-blocker therapies.
Online pulmonary rehabilitation is non-inferior to face-to-face rehabilitation for patients with COPD, according to research presented at ATS 2017.
A new survey shows that home oxygen services create barriers for patients with lung disease.
The TRINITY study reports the significant benefits to extafine triple therapy taken in a single inhaler compared with tiotropium in chronic obstructive pulmonary disease.
Simulated studies were key to the approval of roflumilast for reducing COPD exacerbations.
Patients with COPD and asthma can be characterized by the presence of allergies and more exacerbation with less eosinophilic inflammation.
Study results suggest that gas trapping, not emphysema, is associated with pulmonary vascular remodeling in COPD.
Combination therapy with an inhaled LABA and inhaled corticosteroid did not affect all-cause mortality in patients with COPD compared with inhaled placebo, LABA alone, or corticosterioid alone.
The National Academies of Sciences, Engineering, and Medicine released a report titled "The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendation for Research."
Demographic, family and social factors are important in the role of empowering elderly patients with chronic obstructive pulmonary disease.
Sunovion announces Utibron Neohaler, an inhalation powder for the long term maintenance treatment of airflow obstruction in COPD patients.
The European Respiratory Society and the American Thoracic Society released clinical guidelines for the treatment of patients with chronic obstructive pulmonary disease exacerbations.
Noninvasive positive-pressure ventilation to clear secretions in patients with acute exacerbations of chronic obstructive pulmonary disease may be more beneficial than conventional mechanical ventilation.
Statin use was associated with a 20% lower risk for all-cause mortality and a 45% lower risk for pulmonary-related mortality.
Patients with moderate-to-very-severe chronic obstructive pulmonary disease (COPD) had decreased exacerbations after 3 months of commencing budesonide/formoterol treatment.
Morning symptoms are common among patients with chronic obstructive pulmonary disease (COPD) and are frequently associated with limitations of physical activity.
The 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report was released and includes updated recommendations for the diagnosis and management of chronic obstructive pulmonary disease.
Researchers have suggested a new definition for common smoke-related pulmonary disease (CSPD).
The chronic obstructive pulmonary disease (COPD) Assessment Test (CAT) effectively indicates mortality risk in patients with intestinal lung disease.
Long-term supplemental oxygen does not provide any benefit for patients with stable chronic obstructive pulmonary disease regarding time of death or first hospitalization.